Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
When it comes to micro-caps with a predominantly retail investor following, ST could be described as a 'mega-influencer' [not the flippant TikTok variety!] The next time we win a significant contract it is likely to get a further write up with a 'Well I did tell you' message. The SP should respond positively rather than taking its normal trip further south.
As others have pointed out, it has also given the perma-bears a great opportunity to get out.
I think we could be in for a very exciting and prosperous year. Very best of British [and Irish] luck to fellow holders.
I would regard the situation as similar to a company going into voluntary liquidation [most definitely not a liquidation due to solvency issues]. The shares will probably still be displayed on your account at book cost but nil value. It is very important to read the corporate action statement from the broker, especially if held in an ISA, as they would have to be transferred out. I'm not sure if they are planning to cancel the CREST facility, but if they are, they will sent paper certificates to be held by your broker.
It also appears that there are no plans to set up a matched bargain facility, so it will be impossible monetise your holding at will.
The plan is to liquidate the holding over a medium term period [18-24 months]. As they do this, they should make returns of capital, which of course will be credited to your account as and when.
In my opinion there is massive value on offer here at the current SP for the patient investor [just look at the PDMR dealings]. I think a 30p total return is a possibility, but I would still be more than happy with double the current SP [9p offer] as I write.
I suspect a lot of people hold these in an ISA and are worried about what happens after delisting so have become forced sellers.
A small crumb of comfort in that GBP is down a whopping 19.2% against HKD since suspension.
Really pleased to see that you can now apply for placing shares directly with your broker [in my case A. J. Bell] rather than having to go through Primary Bid. The main advantage of course being that you can use funds in your SIPP or ISA.
Happy to top up here at this price.
If current form is anything to go by should shave at least 0.25p from SP. Good job it wasn't over £10m!
Given the mother of profit warnings, financial irregularities and extremely poor current market sentiment, I would expect the mkt cap at any re-listing to be nowhere near what is usually required for the Main Board. Is it possible that we could be relegated to the GEM? I presume this is a bit like the HK equivalent of AIM from what I have read.
Looks like there has been a complete disconnect between revenue and Mkt cap. I know turnover and top line visibility mean little without a consistently decent operating margin, but to my eyes this is starting to look seriously cheap.
No question that this is at the cutting edge of biotechnology and we are in for an exciting ride over the next few months.
I was interested to hear that identifying a novel drug target for an already patented molecule could in itself spell success.
Big pharma would no doubt give their eye teeth for the data if they thought a treatment for RSV was in the offing.
Glad I decided to top up rather than sell when I received my in specie dividend.
I think it's best just to focus on the news flow rather than the SP!
Well, there we have it, another placing at mate's rates. A jaw dropping 54% discount to estimated fair value of £1.47 per share. They then have the brazenness to boast about the successful £7.3M raised during the year at £1.30. Hardly a sound investment for those poor mugs. Starting to look like a 'lifestyle' company run purely for the benefit of directors. I am not aware of any successful exits and the supposed wonder company PDSB is starting to look like a basket case if the SP is anything to go by.
Did anyone else get the telephone directory sized annual report? Obviously money to burn. At least we got to learn about the bloated salaries and share based payments that the directors enjoy.
I think a drop below the placing price must now be odds on given the current market sentiment and underwhelming results.
Annoyed to think I failed to observe the old stock market saw about never buying into a story. In this case, CF's yarn spinning was so polished he managed to convince himself to buy at 26.5p!
Never mind. Live and learn.
It begs the question: Would the likes of operators such as Serica rather see their hard earned cash permanently disappear in the Chancellor's coffers or asset build by investing at a highly favourable rate in new projects? By the time they come to fruition, the landscape will have changed anyhow [for better or worse]. I wonder who might have suitable assets? Hmmm.